Home  /  Resource Library  /  Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States

Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States

Study examined cardiovascular side effects of ibrutinib and zanubrutinib in treating CLL.